The present application is directed to novel P2X7R antagonists that are indol-3-carboxamide or azaindole-3-carboxamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
本申请涉及新型P2X7R
拮抗剂,其为
吲哚-3-羧
酰胺或
氮杂
吲哚-3-羧
酰胺化合物,包括这些化合物的药物组合物,以及它们用于预防或治疗由P2X7R活性介导的疾病。